CClinicalTrials.gg
CompletedNCT03447080Updated May 13, 2019

Co-ingestion of Rice Bran Soymilk or Plain Soymilk With White Bread: Effects on the Glycaemic and Insulinaemic Response

An interventional study of Control and Control in Diabetes Mellitus, Type 2, sponsored by Singapore Institute of Food and Biotechnology Innovation. Completed at 1 site in Singapore. Open to male participants aged 21 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-05-13.

Sponsored by Singapore Institute of Food and Biotechnology Innovation · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Randomized
Ages
21 Years to 60 Years
Sex
Male
01

Study summary

bread and that rice-bran soymilk will have an additional beneficial effect on the glucose and insulin The proposed research project is important because it will provide, for the first time, evidence on the benefits of the addition of rice-bran to soymilk by measuring the acute effect on the glycaemic and insulinaemic response in co-consumption with a high GI meal in Asians. Investigators hypothesize that soymilk will lower the glycaemic and insulinaemic response of white response. This will have an important implication for public health as investigators will understand better how additional dietary fibre can improve the local diet which is typically of high GI values. Ultimately, results from this project will enable the development of dietary recommendations for better glycaemic control in Asian people.

Read the detailed description

The study will recruit 15-20 young healthy Asian men of Chinese descent. Volunteers will visit Clinical Nutrition Research Centre (CNRC) on 5 occasions: once for consenting and screening procedures (visit 1) and four additional times, interspaced by a minimum of 2 days, to follow a 3 hour test session (Visit 2-5). The study aims to compare the effects of four different test meals , White bread, White bread , Rice-bran soymilk with white bread, Soymilk with white bread, on the glycaemic and insulinaemic response. Visit 1 (screening): For screening, potential subjects will come in the morning after an overnight fast. After obtaining informed consent, a series of screening tests will be conducted, including questionnaires (general health, physical activity and eating behaviour), anthropometry (height, weight, waist and hip circumference), blood pressure, fasting blood glucose, HbA1c and body composition by bioelectrical impedance analysis. Visits 2 to 5 (four experimental trials, in random order): Each of the four study visits will last for approximately 3 hours in the morning, during which the following will take place:During each test session, the subject arrives at the centre between 8:00 and 9:00 in the morning after an overnight fast and has been instructed to avoid any physical activity/exercise and alcohol on the day prior to the test. The session will start by placing an indwelling catheter into a vein in the forearm by trained personnel in a sterile environment. The catheter will be kept patent at all times and left on the forearm until the end of the session. Blood samples will then be taken from the cannula and from a finger prick to measure baseline levels of metabolites. Finger pricks will be done using disposable individual lancets which can cause minimal discomfort. After obtaining baseline blood samples, the subject will be given the test meal to consume within 15 minutes. Following the consumption of the test meal, blood samples (from the cannula and finger pricks) will be collected at periodic intervals (every 15 minutes for the first 90 minutes and every 30 minutes for the remaining 90 minutes). At each time point, a maximum of 5mL of blood will be drawn. In addition, at the same time points, finger prick blood samples will be taken for glucose analysis. At the end of 3 hours of testing, the catheter will be removed and the subject will be free to leave the laboratory. During the entire test session, the subject will have to stay rested and in the laboratory. Television and a workspace will be provided to the subject. In total over the 4 sessions, a maximum of 200 mL of blood (approximately 40 teaspoons) will be collected as part of this study. The blood obtained will be used to measure parameters such as glucose and insulin. Any blood obtained during the course of this study will be stored and analysed for the purposes of this study for a period not exceeding 3 years upon completion of this study. All the study diets will be prepared in the CNRC food preparation kitchen and will use locally sourced ingredients and food purchased from local supermarkets and food distributors.

02

Conditions studied

  • Diabetes Mellitus, Type 2
03

Who can participate

Ages eligible
21 Years to 60 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male
  • Age between 21-60 years
  • Chinese Ethnicity
  • Body mass index between 18.5 - 29 kg/m2
  • Fasting blood glucose \< 7 mmol/L
  • Normal blood pressure (\<140/90 mmHg)

Exclusion criteria

Exclusion Criteria:

  • have metabolic diseases (such as diabetes, hypertension etc.)
  • have glucose-6-phosphate dehydrogenase (G6PD) deficiency
  • Currently on prescription medication that may affect metabolism
  • Intentionally restrict food intake
  • Allergic to wheat bread, rice bran and soya bean
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
17 participants (actual)

Study arms

  • Other
    Control 1

    White bread

    Other: Control

  • Other
    Control 2

    White bread

    Other: Control

  • Experimental
    Rice bran soybean milk

    White Bread with 195ml of rice bran soybean mil

    Other: Ricebran soybean milk

  • Experimental
    Soybean milk

    White Bread with 195ml of soybean milk

    Other: Soybean milk

Interventions

  • OtherControl

    White Bread containing 50g carbohydrate

  • OtherControl

    White Bread containing 50g carbohydrate

  • OtherRicebran soybean milk

    White Bread with rice bran soybean milk

  • OtherSoybean milk

    White Bread with soybean milk

05

What researchers measure

Primary outcomes

  1. Change in postprandial blood glucose over 180 minutes period

    Blood obtained through fingerprick, analysed using Hemocue analyser.

    Time frame: 180 minutes

Secondary outcomes

  1. Change in postprandial plasma insulin over 180 minutes period

    Venous blood obtain through cannula, analysed using Cobas analyser.

    Time frame: 180 minutes

06

Study locations

1 site
  • Clinical Nutrition Reseach Centre
    Singapore, 117599, Singapore
07

Registry details

Key details

Study ID
NCT03447080
Lead sponsor
Singapore Institute of Food and Biotechnology Innovation
Responsible party
JeyaKumar Henry (Principal Investigator, Singapore Institute of Food and Biotechnology Innovation) — Principal investigator
First posted
Feb 27, 2018
Start date
Jun 2, 2017
Primary completion
Jan 18, 2019
Completion
Jan 18, 2019
Last update
May 13, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion